Key Segmentation
By Test Type
-
Polymerase Chain Reaction (PCR)
-
Serology Tests (ELISA, antibody detection)
-
Viral Culture
-
Next-Generation Sequencing (NGS)
-
CRISPR-based Testing (emerging subsegment)
-
Others
By Application
-
Infectious Disease Diagnosis
-
Blood Screening
-
Research & Development
-
Others
By Product
-
Reagents
-
Kits
-
Instruments
-
Consumables & Assay Kits
-
Others
By End User
-
Hospitals & Clinics
-
Diagnostic Laboratories
-
Academic & Research Institutions
-
Pharmaceutical & Biotechnology Companies
-
Home-Based Testing
-
Others
By Testing Methodology (expanded view)
-
Molecular Diagnostics (PCR, NGS, CRISPR)
-
Immunoassays (ELISA, rapid antibody tests)
-
Rapid Diagnostic Kits (POC devices)
-
Centralized Laboratory Testing
-
Decentralized/POC Testing
-
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Ans: North America dominated with a 37.68% share in 2025, while Asia-Pacific is the fastest-growing region, expected to expand at a CAGR of 9.41% during 2026–2035.
Ans: Polymerase Chain Reaction (PCR) dominated with a 41.89% share in 2025, while CRISPR-based Testing are projected to grow at the fastest CAGR of 10.34% during 2026–2035.
Ans: Growth in the virology testing market is driven by rising prevalence of infectious diseases, expanding viral surveillance programs, and increasing demand for accurate molecular diagnostics such as PCR, NGS, and CRISPR-based assays.
Ans: The market is valued at USD 7.05 Billion in 2025 and is projected to reach USD 15.20 Billion by 2035.
Ans: The Virology Testing Market is projected to grow at a CAGR of 8.07% during 2026–2035.